35.65
Vera Therapeutics Inc (VERA) 最新ニュース
Understanding Momentum Shifts in (VERA) - Stock Traders Daily
Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference - The Manila Times
Vera Therapeutics to present May 13 at Bank of America health conference - Stock Titan
IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight - GlobeNewswire Inc.
Pictet Asset Management Holding SA Cuts Stake in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics (VERA) to Release Earnings on Tuesday - MarketBeat
HC Wainwright & Co. Maintains Vera Therapeutics (VERA) Buy Recommendation - MSN
Vera Therapeutics announces refinancing of Oxford debt facility with access to up to $500M in term loans - MSN
Vera Therapeutics announces $200M public offering - MSN
When Will Vera Therapeutics, Inc. (NASDAQ:VERA) Turn A Profit? - 富途牛牛
Avoiding Lag: Real-Time Signals in (VERA) Movement - Stock Traders Daily
Why Vera Therapeutics Stock Rocked the Market on Tuesday - MSN
VERA (Vera Therapeutics Inc.) drops 2.78% after reporting a wider than expected Q4 2025 loss that missed analyst estimates.Retail Trader Ideas - Cổng thông tin điện tử Tỉnh Sơn La
Vera Therapeutics CEO Sells Over 22,000 Shares - National Today
Vera Therapeutics Stock Earns 'Moderate Buy' Rating from Analysts - National Today
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Vera Therapeutics CEO Sells Over $1 Million in Stock - National Today
Fordyce, Vera Therapeutics CEO, sells $1m in VERA stock By Investing.com - Investing.com Australia
Fordyce, Vera Therapeutics CEO, sells $1m in VERA stock - Investing.com
Vera Therapeutics (NASDAQ:VERA) CEO Sells $1,010,991.55 in Stock - MarketBeat
Vera Therapeutics Insider Sold Shares Worth $1,011,051, According to a Recent SEC Filing - marketscreener.com
[Form 4] Vera Therapeutics, Inc. Insider Trading Activity - Stock Titan
Polycythemia Vera Market: Rapid Increment Driven by Innovation - openPR.com
Guggenheim Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $56 - 富途牛牛
Vertex Sues Former Exec To Block Move To Rival - Law360
VERA (NASDAQ: VERA) director sells 16,925 shares for $710,577.51 — Form 144 - Stock Titan
AMI Asset Management Corp Makes New $1.44 Million Investment in Vera Therapeutics, Inc. $VERA - MarketBeat
Panic Selling: Is Vera Therapeutics Inc vulnerable to short sellersQuarterly Risk Review & Verified Short-Term Trading Plans - baoquankhu1.vn
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com
Discipline and Rules-Based Execution in VERA Response - Stock Traders Daily
Vera Therapeutics Announces Inducement Grants - National Today
Vera Therapeutics (VERA) Valuation Check After Recent Share Price Rebound - Sahm
Risk Check: Does Vera Therapeutics Inc align with a passive investing strategyTrade Entry Report & Community Consensus Stock Picks - baoquankhu1.vn
Vera Therapeutics stock rises after crossing above key SMA - Intellectia AI
Published on: 2026-04-11 13:37:36 - baoquankhu1.vn
Can Vera Therapeutics Inc deliver consistent EPS growth2026 Bull vs Bear & High Yield Stock Recommendations - baoquankhu1.vn
Vera Therapeutics Grants Inducement Awards to New Employees Under 2024 Inducement Plan - Quiver Quantitative
Vera Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Vera Therapeutics (NASDAQ:VERA) Stock Price Up 7.1%What's Next? - MarketBeat
Is Vera Therapeutics (VERA) Still Attractive After An 87% One Year Share Price Surge - Yahoo Finance
[ARS] Vera Therapeutics, Inc. SEC Filing - Stock Titan
Board of Vera Therapeutics (VERA) seeks votes on directors, auditor and say-on-pay - Stock Titan
Is It Too Late To Consider Vera Therapeutics (VERA) After Its Recent Share Price Surge? - Sahm
JPMorgan Chase & Co. Sells 228,182 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
BofA Initiates Coverage of Vera Therapeutics (VERA) With a Buy Rating - MSN
Vera Therapeutics Inc. (VERA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vera Therapeutics Adds Experienced Legal Chief As Shares Trade Below Targets - Sahm
Behavioral Patterns of VERA and Institutional Flows - Stock Traders Daily
大文字化:
|
ボリューム (24 時間):